H, Adedoyin A. ADME-Tox in drug discovery: integration of experimental and computational technologies. Drug Discovery Today. Sep 2003, 8 (18): 852–61.

小分子

Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. 2004, 1 (4): 337–341. PMID 24981612. doi:10.1016/j

ADME

GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10

美国癌症研究协会

（原始内容存档于2020-01-03）. Westwell, Andrew D. The war on cancer: an end in sight?. Drug Discovery Today. Conference report 10 (16) (AACR 2005 Annual Meeting, Anaheim, California)

Found in articles

配体效率

C, Metz JT. Ligand efficiency indices as guideposts for drug discovery. Drug Discovery Today. April 2005, 10 (7): 464–469. PMID 15809192. doi:10

藥物設計

H, Adedoyin A. ADME-Tox in drug discovery: integration of experimental and computational technologies. Drug Discovery Today. Sep 2003, 8 (18): 852–61.

小分子

Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today: Technologies. 2004, 1 (4): 337–341. PMID 24981612. doi:10.1016/j

ADME

GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10

美国癌症研究协会

（原始内容存档于2020-01-03）. Westwell, Andrew D. The war on cancer: an end in sight?. Drug Discovery Today. Conference report 10 (16) (AACR 2005 Annual Meeting, Anaheim, California)